Squarepoint Ops LLC Buys 1,406,199 Shares of Corteva, Inc. $CTVA

Squarepoint Ops LLC boosted its stake in Corteva, Inc. (NYSE:CTVA) by 423.6% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,738,139 shares of the company’s stock after buying an additional 1,406,199 shares during the quarter. Squarepoint Ops LLC owned approximately 0.26% of Corteva worth $117,550,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the stock. iSAM Funds UK Ltd grew its holdings in shares of Corteva by 437.8% in the 3rd quarter. iSAM Funds UK Ltd now owns 69,283 shares of the company’s stock worth $4,686,000 after purchasing an additional 56,401 shares during the last quarter. Wellington Management Group LLP lifted its holdings in Corteva by 25.4% during the 3rd quarter. Wellington Management Group LLP now owns 478,933 shares of the company’s stock valued at $32,390,000 after purchasing an additional 96,951 shares during the last quarter. Bank of Hawaii boosted its position in Corteva by 6.3% in the third quarter. Bank of Hawaii now owns 13,924 shares of the company’s stock valued at $942,000 after buying an additional 823 shares in the last quarter. NorthRock Partners LLC grew its stake in Corteva by 15.6% during the third quarter. NorthRock Partners LLC now owns 11,251 shares of the company’s stock worth $761,000 after buying an additional 1,518 shares during the last quarter. Finally, Prudential PLC acquired a new stake in shares of Corteva during the third quarter worth approximately $566,000. 81.54% of the stock is currently owned by institutional investors.

Corteva Trading Down 0.8%

CTVA stock opened at $79.13 on Friday. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a twelve month low of $53.40 and a twelve month high of $80.90. The company has a market cap of $53.22 billion, a P/E ratio of 50.08, a PEG ratio of 2.73 and a beta of 0.72. The business has a fifty day moving average of $74.11 and a 200-day moving average of $69.24.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.22. The business had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The firm’s quarterly revenue was down 1.7% compared to the same quarter last year. During the same quarter last year, the business earned $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities research analysts expect that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be paid a $0.18 dividend. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva’s dividend payout ratio (DPR) is 45.57%.

Insider Activity at Corteva

In related news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the sale, the insider directly owned 8,090 shares of the company’s stock, valued at $619,289.50. The trade was a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 0.14% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on CTVA shares. Mizuho lifted their target price on shares of Corteva from $80.00 to $82.00 and gave the company an “outperform” rating in a research note on Tuesday, February 17th. Wolfe Research lifted their price objective on Corteva from $81.00 to $86.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. Zacks Research lowered Corteva from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 20th. CICC Research increased their target price on Corteva from $70.00 to $80.00 and gave the stock an “outperform” rating in a report on Wednesday, February 11th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on Corteva from $85.00 to $90.00 and gave the stock a “buy” rating in a report on Thursday, February 5th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $82.90.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.